ES2181763T3 - Formulaciones a base de fenbendazol. - Google Patents

Formulaciones a base de fenbendazol.

Info

Publication number
ES2181763T3
ES2181763T3 ES95901776T ES95901776T ES2181763T3 ES 2181763 T3 ES2181763 T3 ES 2181763T3 ES 95901776 T ES95901776 T ES 95901776T ES 95901776 T ES95901776 T ES 95901776T ES 2181763 T3 ES2181763 T3 ES 2181763T3
Authority
ES
Spain
Prior art keywords
fenbendazol
formulations based
fenbendazole
standing
efficacious
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES95901776T
Other languages
English (en)
Inventor
Leslie E Kyle
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Akzo Nobel NV
Original Assignee
Akzo Nobel NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel NV filed Critical Akzo Nobel NV
Application granted granted Critical
Publication of ES2181763T3 publication Critical patent/ES2181763T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Lock And Its Accessories (AREA)
  • Chemical And Physical Treatments For Wood And The Like (AREA)
  • Structures Of Non-Positive Displacement Pumps (AREA)

Abstract

ESTA SOLICITUD SE REFIERE A UNA FORMULACION ACUOSA DE FENBENDAZOL QUE ES ESTABLE Y EFICAZ, NO SE AGLOMERA AL ESTAR DE PIE Y EN DONDE EL FENBENDAZOL PERMANECE EN SUSPENSION AL ESTAR DE PIE DURANTE VEINTICUATRO HORAS.
ES95901776T 1993-11-10 1994-11-09 Formulaciones a base de fenbendazol. Expired - Lifetime ES2181763T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/149,877 US5538989A (en) 1993-11-10 1993-11-10 Fenbendazole formulations

Publications (1)

Publication Number Publication Date
ES2181763T3 true ES2181763T3 (es) 2003-03-01

Family

ID=22532170

Family Applications (1)

Application Number Title Priority Date Filing Date
ES95901776T Expired - Lifetime ES2181763T3 (es) 1993-11-10 1994-11-09 Formulaciones a base de fenbendazol.

Country Status (14)

Country Link
US (1) US5538989A (es)
EP (1) EP0727996B1 (es)
JP (1) JP3523260B2 (es)
KR (1) KR960705563A (es)
AT (1) ATE221780T1 (es)
BR (1) BR9408023A (es)
CA (1) CA2176223C (es)
DE (1) DE69431162T2 (es)
DK (1) DK0727996T3 (es)
ES (1) ES2181763T3 (es)
MY (1) MY115429A (es)
PH (1) PH31320A (es)
PT (1) PT727996E (es)
WO (1) WO1995013065A1 (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IES66993B2 (en) * 1995-12-01 1996-02-21 Chanelle Chemicals Ltd A process
US5861142A (en) * 1996-03-25 1999-01-19 Schick; Mary Pichler Method for promoting hair, nail, and skin keratinization
CZ301938B6 (cs) * 1999-09-03 2010-08-04 Janssen Pharmaceutica N. V. Veterinární preparát pro podávání ve vode nerozpustných léku cílovému zvíreti prostrednictvím napájecího systému
GB0105358D0 (en) * 2001-03-03 2001-04-18 Fluid Technologies Ltd Absorbent materials
US7396819B2 (en) * 2003-08-08 2008-07-08 Virbac Corporation Anthelmintic formulations
WO2005094210A2 (en) * 2004-03-12 2005-10-13 The Hartz Mountain Corporation Multi-action anthelmintic formulations
EP1734954A4 (en) * 2004-04-07 2007-05-30 Intervet Int Bv EFFECTIVE COMPOSITION OF A BENZIMIDAZOLE, AVERMECTIN AND PRAZIQUANTEL AND RELEVANT APPLICATION METHOD
WO2007144362A1 (en) 2006-06-14 2007-12-21 Intervet International B.V. A suspension comprising benzimidazole carbamate and a polysorbate
EP2409683A1 (en) 2010-07-06 2012-01-25 KRKA, D.D., Novo Mesto Stable aqueous formulations comprising poorly water soluble active ingredients
PH12012502076A1 (en) * 2010-08-24 2013-02-04 Otsuka Pharma Co Ltd Suspension and cake composition containing carbostyryl derivative and silicone oil and/or silicone oil derivative
KR102419769B1 (ko) * 2016-08-11 2022-07-13 아다미스 파마슈티칼스 코포레이션 약물 조성물
CN106727304B (zh) * 2017-04-06 2019-09-03 江西博莱大药厂有限公司 一种芬苯达唑混悬剂及其制备方法
EP3720844A4 (en) 2017-12-08 2021-08-11 Adamis Pharmaceuticals Corporation MEDICINAL COMPOSITIONS
WO2024026463A1 (en) * 2022-07-28 2024-02-01 Happy Healing Inc. Composition for nasal delivery of an active compound
CN116602964B (zh) * 2023-07-18 2023-09-22 山东国邦药业有限公司 一种芬苯达唑粉及其制备方法与应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE684059A (es) * 1965-07-15 1967-01-13
BE793358A (fr) * 1971-12-27 1973-06-27 Hoechst Ag Nouveaux derives de 2-carbalcoxy-amino-benzimidazole presentantune activite anthelmintique et leur procede de preparation
US3897559A (en) * 1972-07-06 1975-07-29 Lilly Co Eli Anthelmintic phenylhydrazones
FR2336931A1 (fr) * 1975-12-30 1977-07-29 Dick Pierre Compositions anthelminthiques a base de benzimidazoles
US4197307A (en) * 1977-04-12 1980-04-08 Ciba-Geigy Corporation 2-Alkylthio-, 2-alkylsulphinyl- and 2-alkylsulfonyl-6-phenylbenzimidazoles as anthelmintic agents
ATE29217T1 (de) * 1982-03-30 1987-09-15 Hoechst Uk Ltd Anthelmintika.

Also Published As

Publication number Publication date
EP0727996A1 (en) 1996-08-28
PH31320A (en) 1998-07-06
PT727996E (pt) 2002-11-29
CA2176223A1 (en) 1995-05-18
MY115429A (en) 2003-06-30
DK0727996T3 (da) 2002-11-18
DE69431162D1 (en) 2002-09-12
WO1995013065A1 (en) 1995-05-18
KR960705563A (ko) 1996-11-08
DE69431162T2 (de) 2002-12-12
EP0727996B1 (en) 2002-08-07
BR9408023A (pt) 1996-12-10
JP3523260B2 (ja) 2004-04-26
EP0727996A4 (en) 1996-11-06
JPH09506086A (ja) 1997-06-17
CA2176223C (en) 2003-02-11
ATE221780T1 (de) 2002-08-15
US5538989A (en) 1996-07-23

Similar Documents

Publication Publication Date Title
DK0781551T3 (da) Retinoid-formuleringer i porøse mikrosfærer til nedsat irritation og forbedret stabilitet
EP0727996A4 (en) Fenbendazole formulations
YU47204B (sh) Derivati didehidro-vitamina d3
ATE173402T1 (de) Lyophilisierte stammzellenfaktor formulierungen
ES2140565T3 (es) Nuevos derivados de pirazina-carboxamida, su preparacion y su utilizacion en medicamentos.
FI962445A7 (fi) Paroksetiinitabletteja ja menetelmä niiden valmistamiseksi
PL285248A1 (en) Method of obtaining novel aminophenol derivatives
ES2026754A6 (es) Procedimiento de obtencion de una composicion para el tratamiento cosmetico de la piel y del cuerpo.
UA10208A (uk) Дерматологічний косметичний засіб
TR200001102T2 (tr) İkameli tetrahidropirimidinen türevleri, üretimleri ve kullanımları.
ES2105605T3 (es) Antagonistas de taquiquinina, su preparacion y utilizacion en formulaciones farmaceuticas.
AU4714297A (en) Metalloproteinase inhibitors
DK0391185T3 (da) 1,8-Naphthyridiner
BG100248A (bg) Инхибитори на скваленсинтетаза
AU645092B2 (en) Anti-actinic agent
FI910112A0 (fi) Preparat foer lokalt bruk.
AU8375891A (en) Antioxidant system based on a basic amino acid in combination with a tocopherol or derivative thereof and a nonthiolated polypeptide, and compositions containing the same
TW345602B (en) Storage-stable liquid brightener formulations
AU7028798A (en) Use of 2-methylthiazolidine-2,4-dicarboxylic acid as mucolytic agent
DE69431662D1 (de) Stabilisierte tablettenformulierung
ATE204286T1 (de) Modifizierte alpha-d-glcp-(1,2)-alpha-d-glcp-(1, 3)-alpha-d-glcp-analoge
AU6312996A (en) Compositions
SV1990000045A (es) Preparacion de cicloalcano [b] dehidroindol e-inosulfonamidas sustituidas, ref. le a 27 157-sv.
IT1201431B (it) Composizioni farmaceutiche e cosmetiche contenenti come ingrediente attivo acetil -10 triacetossi-1,8,9 antracene